JR Pharma Engineering ApS — Credit Rating and Financial Key Figures

CVR number: 42398993
Hyldegårds Tværvej 47, 2920 Charlottenlund

Income statement (kDKK)

2021
2022
2023
Fiscal period length121212
Net sales1 481.601 865.521 959.82
External services-20.73-40.02
Gross profit1 460.871 806.001 947.12
Costs of management-19.50-12.70
Employee benefit expenses- 717.18
Total depreciation-5.60-25.06-1.56
EBIT738.09828.35842.69
Other financial expenses-2.94-1.06-0.13
Pre-tax profit735.16827.29842.56
Income taxes- 161.84- 182.00- 191.84
Net earnings573.31645.28650.72

Assets (kDKK)

2021
2022
2023
Intangible assets total
Tangible assets total
Investments total
Long term receivables total
Inventories total
Current trade debtors330.50468.15421.31
Current deferred tax assets200.00
Short term receivables total530.50468.15421.31
Cash and bank deposits388.35765.34668.10
Cash and cash equivalents388.35765.34668.10
Balance sheet total (assets)918.851 233.491 089.41

Equity and liabilities (kDKK)

2021
2022
2023
Share capital41.7840.0040.00
Retained earnings-0.001.941.94
Profit of the financial year573.31645.28650.72
Shareholders equity total615.09687.23692.66
Non-current liabilities total
Current trade creditors31.680.78
Short-term deferred tax liabilities161.84343.85111.05
Other non-interest bearing current liabilities141.92170.73284.92
Current liabilities total303.76546.26396.75
Balance sheet total (liabilities)918.851 233.491 089.41
Try the full version of our system for free
Bankruptcy risk visualization example

... and more!

No registration needed.